Last reviewed · How we verify

NCT06947603

Effect of Inula Viscosa Extract on Postoperative Bleeding and Healing After Lower Third Molar Surgery

Completed NA Last updated 27 April 2025
What this trial tests

NA trial testing inula viscosa extract in Bleeding in 30 participants. Completed in 29 March 2025.

Timeline
20 November 2023
Primary endpoint
1 March 2025
29 March 2025

Quick facts

Lead sponsorAl-Wataniya University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date20 November 2023
Primary completion1 March 2025
Estimated completion29 March 2025
Sites1 location across Syria

Drugs / interventions tested

Conditions studied

Sponsor

Al-Wataniya University

Who can join

Adults 18 to 35, any sex, with Bleeding or Healing Surgical Wounds. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In oral surgery, the operation of the impacted third molar is one of the most common surgical procedures performed by oral and maxillofacial surgeons .Several attempts have been made to reduce the postoperative outcome of the removal of the third molar post-surgery.The bioactive components in Inula extracts consist of sesquiterpene lactones, and the major components are alantolactone and isoalantolactone .\]. Inula has Antioxidant, antihyperglycemic, antimicrobial, antibacterial, antifungal, anticancer and anti-inflammatory effects. the purpose of this study was to assess the effects of inula viscosa on the postoperative period of the third molar surgery by evaluating bleeding, and healing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bleeding

Currently open trials in the same condition.

Other Al-Wataniya University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06947603.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing